Jia Yin

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 12

Top Topics

Acute Myeloid Leukemia

Extracorporeal Membrane Oxygenation

Top Venues

Blood cancer journal

Annals of hematology

American journal of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Zhibo Zhang, Jia Yin, Guoli Lian, Xiebing Bao, Meng Hu, Zhenfang Liu, Yuan Yu, Ruihua Mi, Yabei Zuo, Pengcheng Shi, Weiyan Zheng, Qian Jiang, Hongying Chao, Peifang Xiao, Weijuan Yu, Yanqiu Han, Yu Wu, Yan Zeng, De-Pei Wu, Xiaofei Yang, Su-Ning Chen
A multi-center retrospective comparison between systemic mastocytosis with t(8;21) AML and KIT mutant t(8;21) AML. Blood advances (2024)
Zhibo Zhang, Jia Yin, Guoli Lian, Xiebing Bao, Meng Hu, Zhenfang Liu, Yuan Yu, Ruihua Mi, Yabei Zuo, Pengcheng Shi, Weiyan Zheng, Qian Jiang, Hongying Chao, Peifang Xiao, Weijuan Yu, Yanqiu Han, Yu Wu, Yan Zeng, De-Pei Wu, Xiaofei Yang, Su-Ning Chen
A multicenter retrospective comparison between systemic mastocytosis with t(8;21) AML and KIT mutant t(8;21) AML. Blood advances 8 (4) (2024)
Zhibo Zhang, Jia Yin, Guoli Lian, Xiebing Bao, Meng Hu, Zhenfang Liu, Yuan Yu, Ruihua Mi, Yabei Zuo, Pengcheng Shi, Weiyan Zheng, Qian Jiang, Hongying Chao, Peifang Xiao, Weijuan Yu, Yanqiu Han, Yu Wu, Yan Zeng, De-Pei Wu, Xiaofei Yang, Su-Ning Chen
A multicenter retrospective comparison between systemic mastocytosis with t(8;21) AML and KIT mutant t(8;21) AML. Blood advances 8 (4) (2024)
Si-Ning Liu, Xin-Yue Zhang, Haiping Dai, Wei Cui, Jia Yin, Zheng Li, Xiao Yang, Chunxiu Yang, Sheng-Li Xue, Huiying Qiu, Miao Miao, Suning Chen, Zhengming Jin, Chengcheng Fu, Caixia Li, Aining Sun, Yue Han, Ying Wang, Lei Yu, De-Pei Wu, Qingya Cui, Xiao-Wen Tang
Which one is better for refractory/relapsed acute B-cell lymphoblastic leukemia: Single-target (CD19) or dual-target (tandem or sequential CD19/CD22) CAR T-cell therapy? Blood cancer journal 13 (1) (2023)
Si-Ning Liu, Xin-Yue Zhang, Haiping Dai, Wei Cui, Jia Yin, Zheng Li, Xiao Yang, Chunxiu Yang, Sheng-Li Xue, Huiying Qiu, Miao Miao, Suning Chen, Zhengming Jin, Chengcheng Fu, Caixia Li, Aining Sun, Yue Han, Ying Wang, Lei Yu, De-Pei Wu, Qingya Cui, Xiao-Wen Tang
Which one is better for refractory/relapsed acute B-cell lymphoblastic leukemia: Single-target (CD19) or dual-target (tandem or sequential CD19/CD22) CAR T-cell therapy? Blood cancer journal 13 (1) (2023)
Si-Ning Liu, Xin-Yue Zhang, Haiping Dai, Wei Cui, Jia Yin, Zheng Li, Xiao Yang, Chunxiu Yang, Sheng-Li Xue, Huiying Qiu, Miao Miao, Suning Chen, Zhengming Jin, Chengcheng Fu, Caixia Li, Aining Sun, Yue Han, Ying Wang, Lei Yu, De-Pei Wu, Qingya Cui, Xiao-Wen Tang
Which one is better for refractory/relapsed acute B-cell lymphoblastic leukemia: Single-target (CD19) or dual-target (tandem or sequential CD19/CD22) CAR T-cell therapy? Blood cancer journal 13 (1) (2023)
Si-Ning Liu, Xin-Yue Zhang, Haiping Dai, Wei Cui, Jia Yin, Zheng Li, Xiao Yang, Chunxiu Yang, Sheng-Li Xue, Huiying Qiu, Miao Miao, Suning Chen, Zhengming Jin, Chengcheng Fu, Caixia Li, Aining Sun, Yue Han, Ying Wang, Lei Yu, De-Pei Wu, Qingya Cui, Xiao-Wen Tang
Which one is better for refractory/relapsed acute B-cell lymphoblastic leukemia: Single-target (CD19) or dual-target (tandem or sequential CD19/CD22) CAR T-cell therapy? Blood cancer journal 13 (1) (2023)
De-Yuan Hu, Man Wang, Kai Shen, Jin-Lan Pan, Yu-Sha Guo, Zhi-Bo Zhang, Feng-Hong Zhang, Jia Yin, Su-Ning Chen
A new breakpoint fusion gene involving KMT2A::EDC4 rearrangement in de novo acute myeloid leukemia. International journal of laboratory hematology (2023)
Si-Ning Liu, Xin-Yue Zhang, Haiping Dai, Wei Cui, Jia Yin, Zheng Li, Xiao Yang, Chunxiu Yang, Sheng-Li Xue, Huiying Qiu, Miao Miao, Suning Chen, Zhengming Jin, Chengcheng Fu, Caixia Li, Aining Sun, Yue Han, Ying Wang, Lei Yu, De-Pei Wu, Qingya Cui, Xiao-Wen Tang
Which one is better for refractory/relapsed acute B-cell lymphoblastic leukemia: Single-target (CD19) or dual-target (tandem or sequential CD19/CD22) CAR T-cell therapy? Blood cancer journal 13 (1) (2023)
Si-Ning Liu, Xin-Yue Zhang, Haiping Dai, Wei Cui, Jia Yin, Zheng Li, Xiao Yang, Chunxiu Yang, Sheng-Li Xue, Huiying Qiu, Miao Miao, Suning Chen, Zhengming Jin, Chengcheng Fu, Caixia Li, Aining Sun, Yue Han, Ying Wang, Lei Yu, De-Pei Wu, Qingya Cui, Xiao-Wen Tang
Which one is better for refractory/relapsed acute B-cell lymphoblastic leukemia: Single-target (CD19) or dual-target (tandem or sequential CD19/CD22) CAR T-cell therapy? Blood cancer journal 13 (1) (2023)
Wei Cui, Xin-Yue Zhang, Zheng Li, Hai-Ping Dai, Jia Yin, Qing-Ya Cui, Si-Ning Liu, Li-Qing Kang, Lei Yu, De-Pei Wu, Xiao-Wen Tang
Long-term follow-up of tandem CD19/CD22 CAR T-Cells in r/r B-ALL patients with high-risk features. American journal of hematology (2023)
Jia Yin, Feng Zhu, Zhi-Bo Zhang, Qian Wang, Xue-Feng He, Qian Wu, Jing-Ren Zhang, Ai-Ning Sun, De-Pei Wu, Xiao-Fei Yang, Su-Ning Chen
Rapid and deep response to avapritinib in heavily treated acute myeloid leukemia with t (8;21) and KIT mutation. Annals of hematology 101 (10) (2022)